CyclophosphamideEpirubicinFluorouracilAntineoplastic Combined Chemotherapy ProtocolsDrug Administration ScheduleDoxorubicinLeucovorinBreast NeoplasmsAntimetabolites, AntineoplasticMethotrexateAntibiotics, AntineoplasticTreatment OutcomeChemotherapy, AdjuvantCisplatinVincristineInfusions, IntravenousCombined Modality TherapyAntineoplastic Agents, AlkylatingDisease-Free SurvivalPhosphoramide MustardsSurvival AnalysisTaxoidsPaclitaxelPrednisoneOrganoplatinum CompoundsSurvival RateLeukopeniaDihydrouracil Dehydrogenase (NADP)Dose-Response Relationship, DrugGranulocyte Colony-Stimulating FactorAntineoplastic AgentsEtoposideNeutropeniaDeoxycytidineNeoadjuvant TherapyAdenocarcinomaNeoplasm MetastasisRemission InductionImmunosuppressive AgentsNeoplasm StagingThiotepaPulse Therapy, DrugTime FactorsColorectal NeoplasmsThymidylate SynthaseVinblastineRazoxaneInjections, IntravenousCamptothecinStomach NeoplasmsAnthracyclinesNauseaDrug EvaluationUracilFollow-Up StudiesStomatitisAlopeciaDrug Therapy, CombinationMitomycinAdministration, OralFloxuridineIfosfamideHematologic DiseasesVomitingTegafurColonic NeoplasmsBusulfanDrug SynergismSemustineLymphoma, Non-HodgkinPrednisoloneCarboplatinNeoplasm Recurrence, LocalDrug Resistance, NeoplasmLymphatic MetastasisProspective StudiesPrognosisMitoxantroneFluorodeoxyuridylateAntibodies, Monoclonal, Murine-DerivedMastectomy, RadicalMaximum Tolerated Dose